Price Alert

Ironwood Pharmaceuticals ... (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

1.09

0.02 (1.87%)

At close: Aug 15, 2025, 10:06 AM

Ironwood Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	85.24M	41.14M	90.55M	91.59M	94.4M	74.88M	117.55M	113.74M	107.38M	104.06M	107.2M	108.64M	97.23M	97.53M	117.13M	103.75M	104.03M	88.84M
Cost of Revenue	467K	479K	78.48M	29.83M	506K	513K	512K	507K	270K	286K	340K	363K	11.45M	355K	358K	10.91M	12.16M	15.48M
Gross Profit	84.77M	40.66M	90.55M	61.77M	93.89M	74.36M	117.04M	113.23M	107.11M	103.78M	106.86M	108.27M	85.78M	97.17M	116.77M	92.84M	91.87M	73.36M
Operating Income	45.32M	-29.11M	31.49M	25.64M	24.98M	11.02M	37.59M	40.02M	-1.08B	60.1M	68.36M	68.47M	55.66M	57.85M	56.59M	65.17M	65.1M	45.4M
Interest Income	818K	869K	778K	1.15M	1.37M	1.17M	1.19M	1.75M	8.76M	7.27M	5.45M	2.81M	1.02M	230K	180K	178K	172K	196K
Pretax Income	37.82M	-36.27M	24M	17.37M	18.88M	4.96M	30.36M	31.93M	-1.08B	65.86M	72.27M	69.91M	53.78M	56.47M	46.26M	59.67M	54.37M	40.36M
Net Income	23.6M	-37.39M	2.26M	3.65M	-860K	-4.16M	-1.09M	15.32M	-1.06B	45.71M	48.87M	50.32M	37.08M	38.8M	41.37M	55.84M	391.3M	39.93M
Selling & General & Admin	16.8M	24.26M	33.59M	36.11M	36.96M	37.6M	37.57M	32.35M	52.48M	31.12M	28.39M	28.62M	30.12M	28.86M	28.69M	27.74M	27.05M	27.65M
Research & Development	23.37M	27.43M	25.39M	29.83M	30.39M	25.82M	35.06M	32.98M	1.13B	12.85M	10.45M	11.54M	11.45M	10.82M	31.85M	10.91M	12.16M	15.48M
Other Expenses	-467K	-8.87M	-78.41M	-29.81M	2.07M	-25.38M	n/a	-24.4M	14.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	39.7M	42.82M	-19.42M	36.13M	69.42M	38.04M	72.63M	40.93M	1.17B	43.96M	38.84M	40.16M	41.58M	39.68M	60.54M	38.65M	39.22M	43.14M
Interest Expense	8.36M	8.07M	8.91M	9.42M	7.47M	7.23M	8.42M	9.84M	1.84M	1.53M	1.53M	1.52M	2.21M	2.34M	7.95M	7.84M	7.73M	7.63M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	40.17M	70.25M	59.05M	65.96M	69.42M	63.86M	79.96M	73.72M	1.19B	43.96M	38.84M	40.16M	41.58M	39.68M	60.54M	38.65M	39.22M	43.14M
Income Tax Expense	14.22M	1.11M	21.74M	13.72M	19.74M	9.12M	32.1M	17.98M	13.26M	20.15M	23.4M	19.59M	16.7M	17.66M	4.88M	3.83M	-336.93M	432K
Shares Outstanding (Basic)	161.72M	160.97M	159.9M	159.71M	159.01M	157.7M	156.01M	155.89M	155.37M	154.45M	153.34M	180.48M	153.3M	184.27M	163.29M	162.74M	161.95M	160.97M
Shares Outstanding (Diluted)	161.72M	160.97M	160.42M	160.23M	159.01M	157.7M	156.01M	186.89M	155.37M	186.68M	185.19M	184.47M	184.88M	189.54M	165.63M	165.24M	163.5M	162.35M
EPS (Basic)	0.15	-0.23	0.01	0.02	-0.01	-0.03	-0.01	0.10	-6.84	0.30	0.32	0.28	0.24	0.21	0.25	0.34	2.42	0.25
EPS (Diluted)	0.14	-0.23	0.01	0.02	-0.01	-0.03	-0.01	0.08	-6.84	0.25	0.26	0.27	0.21	0.20	0.25	0.34	2.39	0.25
EBITDA	46.65M	-27.72M	33.8M	27.3M	26.85M	12.29M	39.3M	42.28M	-1.07B	67.67M	74.13M	71.79M	56.35M	59.16M	54.56M	67.87M	62.5M	48.39M
EBIT	46.18M	-28.2M	33.32M	26.79M	26.35M	11.78M	38.78M	41.77M	-1.07B	66.99M	75.24M	71.03M	55.48M	58.27M	54.21M	67.09M	61.69M	47.59M
Depreciation & Amortization	467K	479K	485K	507K	506K	513K	512K	507K	270K	286K	340K	363K	360K	355K	358K	358K	396K	410K